Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2012
DOI: 10.1002/ar.22611
|View full text |Cite
|
Sign up to set email alerts
|

TFPI‐2 Downregulates Multidrug Resistance Protein in 5‐FU‐Resistant Human Hepatocellular Carcinoma BEL‐7402/5‐FU Cells

Abstract: Tissue factor pathway inhibitor-2 (TFPI-2) is known to induce apoptosis and to suppress tumor metastasis in several types of cancer cells. However, there is little known about its reversal effect on chemoresistant tumor cells. This study investigated the effect of TFPI-2 in 5-fluorouracil (5-FU)-resistant human hepatocellular cancer BEL-7402/5-FU cells in vitro. We constructed TFPI-2 overexpression BEL-7402/5-FU cell lines and explored resistance index (RI) of 5-FU, function of the P-glycoprotein (P-gp) efflux… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 22 publications
(22 reference statements)
0
9
0
Order By: Relevance
“…Human HCC cell lines — SMMC-7721, HepG2, Huh7, Hep3B, MHCC97H, HCCLM3 and Bel-7402 — were purchased from Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Science. Drug resistant cell lines — Bel-7402/5-Fludrouracil (5-FU) and Bel-7402/Adriamycin (ADM) — were obtained by exposing Bel-7402 to stepwise increases in 5-FU or ADM according to reported methods [ 21 , 22 ].…”
Section: Methodsmentioning
confidence: 99%
“…Human HCC cell lines — SMMC-7721, HepG2, Huh7, Hep3B, MHCC97H, HCCLM3 and Bel-7402 — were purchased from Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Science. Drug resistant cell lines — Bel-7402/5-Fludrouracil (5-FU) and Bel-7402/Adriamycin (ADM) — were obtained by exposing Bel-7402 to stepwise increases in 5-FU or ADM according to reported methods [ 21 , 22 ].…”
Section: Methodsmentioning
confidence: 99%
“…The PI3K inhibitor LY294002, the p38 MAPK inhibitor SB203580, and the JNK inhibitor SP600125 were tested and did not affect P-glycoprotein expression [25]. Various reports have described the association between p38 MAPK and P-glycoprotein: the activation of p38 MAPK reduced the expression of MDR1 and MRP1 mRNAs in 5fluorouracil-resistant BEL-7402/5-FU cells [29], whereas the inhibition of p38 MAPK reduced the activator protein-1 (AP-1) activity and MDR1 gene expression in vincristineresistant SGC7901/VCR cells [30]. SB203580 also reversed the P-glycoprotein-mediated MDR of L1210/VCR cells without affecting P-glycoprotein expression [31].…”
Section: Modulation Of P-glycoprotein Expression By the Mitogen-mentioning
confidence: 99%
“…Overexpression of TFPI-2 could inhibit cell migration 24 , proliferation 25 , and promote cell apoptosis 26 in glioma cells. Moreover, TFPI-2 inhibits the function of P-glycoprotein efflux pump, resulting in reduced TMZ efflux in GB cells 27 . However, whether TFPI-2 is the potential target of lncRNA AC003092.1 in TMZ-resistant GB remains unclear.…”
Section: Introductionmentioning
confidence: 99%